Highbridge Capital Management’s Allergan plc AGN Stock Holding History

Highbridge Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-252,200	Closed	-$42.4M	–	1465
2018 Q1	$42.4M	Sell	252,200 -107,700	-30%	-$18.1M	0.69%	16
2017 Q4	$58.9M	Sell	359,900 -140,300	-28%	-$25.2M	1.05%	9
2017 Q3	$103M	Buy	+500,200	New	+$116M	1.53%	2
2016 Q1	–	Sell	-100,000	Closed	-$31.3M	–	1952
2015 Q4	$31.3M	Hold	100,000	–	–	0.48%	43
2015 Q3	$27.2M	Buy	+100,000	New	+$30.7M	0.42%	51
2015 Q2	–	Sell	-450,000	Closed	-$134M	–	1778
2015 Q1	$134M	Buy	450,000 +298,900	+198%	+$85.2M	1.85%	1
2014 Q4	$38.9M	Buy	+151,100	New	+$37.8M	0.5%	56
2014 Q3	–	Sell	-60,000	Closed	-$13.4M	–	1442
2014 Q2	$13.4M	Buy	+60,000	New	+$12.4M	0.16%	152
2014 Q1	–	Sell	-1,500	Closed	-$253K	–	1320
2013 Q4	$253K	Buy	+1,500	New	+$234K	﹤0.01%	901

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Highbridge Capital Management's AGN Position: Q4 2018 in Review

Highbridge Capital Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 14,055 shares — an estimated $2.68M sold.

Highbridge Capital Management first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $43.5M in Q3 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

Highbridge Capital Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 14,055 Allergan plc shares in Q4 2018, an estimated $2.68M.
Highbridge Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
Highbridge Capital Management's Allergan plc position peaked at $43.5M in Q3 2017.
1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.